Z-360 Plus GEM in Subjects With Metastatic Pancreatic Adenocarcinoma
Status:
Completed
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to compare the efficacy of GEM plus Z-360 versus GEM
plus placebo on the overall survival (OS) in subjects with metastatic Pancreatic
Adenocarcinoma.